Dan Liu

Prof. Dan Liu


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Chinese Journal of Organic Chemistry
Verified
Journal Article
Closed access
PDF file
CLCuiping Lü
Cuiping Lü
QSQilong Shen
Qilong Shen
DLDan Liu
Dan Liu

24 May 2023 in Nanomaterials
Verified
Journal Article
Open access
PDF file
CYChi Yu
Chi Yu
WJWei Jiang
Wei Jiang
BLBin Li
Bin Li
Yong HuYong Hu
Yong Hu
DLDan Liu
Dan Liu
Integrins are heterodimeric transmembrane proteins that mediate adhesive connections between cells and their surroundings, including surrounding cells and the extracellular matrix (ECM). They modulate tissue mechanics and regulate intracellular signaling, including cell generation, survival, proliferation, and differentiation, and the up-regulation of integrins in tumor cells has been confirmed to be associated with tumor development, invasion, angiogenesis, metastasis, and therapeutic resistance. Thus, integrins are expected to be an effective target to improve the efficacy of tumor therapy. A variety of integrin-targeting nanodrugs have been developed to improve the distribution and penetration of drugs in tumors, thereby, improving the efficiency of clinical tumor diagnosis and treatment. Herein, we focus on these innovative drug delivery systems and reveal the improved efficacy of integrin-targeting methods in tumor therapy, hoping to provide prospective guidance for the diagnosis and treatment of integrin-targeting tumors.

23 December 2015 in Molecules
Verified
Journal Article
Open access
PDF file
DLDan Liu
Dan Liu
Tian LuanTian Luan
Tian Luan
JKJian Kong
Jian Kong
YZYing Zhang
Ying Zhang
HWHaifeng WANG
Haifeng WANG
Twenty-two 7-fluoro (or 8-methoxy)-4-anilinoquinolines compounds were designed and synthesized as potentially potent and selective antitumor inhibitors. All the prepared compounds were evaluated for their in vitro antiproliferative activities against the HeLa and BGC823 cell lines. Ten compounds (1a–g; 2c; 2e and 2i) exhibited excellent antitumor activity superior to that of gefitinib. Among the ten compounds; seven (1a–c; 1e–1g and 2i) displayed excellent selectivity for BGC823 cells. In particular; 1f and 2i exhibited potent cytotoxic activities against HeLa cells and BGC823 cells with better IC50 values than gefitinib.

20 August 2024 in Chemical Research in Chinese Universities
Verified
Journal Article
Closed access
PDF file
WJWei Jiang
Wei Jiang
JCJiayan Chen
Jiayan Chen
HWHaifeng Wang
Haifeng Wang
AXAiqi Xue
Aiqi Xue
XZXinyang Zhang
Xinyang Zhang
DLDan Liu
Dan Liu